Leukemia & Lymphoma, Volume 48, Issue 12 (2007)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Leukemia & Lymphoma, Volume 48, Issue 12 (2007)

See all volumes and issues
Vol 65, 2024 Vol 64, 2023 Vol 63, 2022 Vol 62, 2021 Vol 61, 2020 Vol 60, 2019 Vol 59, 2018 Vol 58, 2017 Vol 57, 2016 Vol 56, 2015 Vol 55, 2014 Vol 54, 2013 Vol 53, 2012 Vol 52, 2011 Vol 51, 2010 Vol 50, 2009 Vol 49, 2008 Volume 48, 2007 Vol 47, 2006 Vol 46, 2005 Vol 45, 2004 Vol 44, 2003 Vol 43, 2002 Vol 42, 2001 Vol 41, 2001 Vol 40, 2000-2001 Vol 39, 2000 Vol 38, 2000 Vol 37, 2000 Vol 36, 1999-2000 Vol 35, 1999 Vol 34, 1999 Vol 33, 1999 Vol 32, 1998-1999 Vol 31, 1998 Vol 30, 1998 Vol 29, 1998 Vol 28, 1997-1998 Vol 27, 1997 Vol 26, 1997 Vol 25, 1997 Vol 24, 1996-1997 Vol 23, 1996 Vol 22, 1996 Vol 21, 1996 Vol 20, 1995-1996 Vol 19, 1995 Vol 18, 1995 Vol 17, 1995 Vol 16, 1995 Vol 15, 1995 Vol 16, 1995 Vol 15, 1995 Vol 14, 1994 Vol 13, 1994 Vol 12, 1993-1994 Vol 11, 1993 Vol 10, 1993 Vol 9, 1993 Vol 8, 1992 Vol 7, 1992 Vol 6, 1991-1992 Vol 5, 1991 Vol 4, 1991 Vol 3, 1990-1991 Vol 2, 1990 Vol 1, 1989-1990
Download citations Download PDFs

Obituary

Obituary
Pages: 2277-2278
Published online: 01 Jul 2009
CitationforObituary | Full Text | References | PDF (660.1 KB)
  • 36 Views
  • 0 CrossRef citations
  • 0Altmetric
Leukemia – Past and Present A scientific meeting in memory of Prof David Galton
Page: 2279
Published online: 01 Jul 2009
CitationforLeukemia – Past and Present A scientific meeting in memory of Prof David Galton | Full Text | PDF (39.2 KB)
  • 8 Views
  • 0 CrossRef citations
  • 0Altmetric
Godwits and blast crises: In memory of David Galton
Mel Greaves
Pages: 2280-2282
Published online: 01 Jul 2009
First Page PreviewforGodwits and blast crises: In memory of David Galton | Full Text | References | PDF (201.7 KB)
  • 22 Views
  • 0 CrossRef citations
  • 0Altmetric
FAB and beyond
Barbara Bain
Pages: 2282-2283
Published online: 01 Jul 2009
CitationforFAB and beyond | Full Text | References | PDF (39 KB)
  • 45 Views
  • 1 CrossRef citations
  • 0Altmetric
The changing face of chronic lymphocytic leukemia
Daniel Catovsky
Pages: 2283-2284
Published online: 01 Jul 2009
CitationforThe changing face of chronic lymphocytic leukemia | Full Text | References | PDF (40.7 KB)
  • 18 Views
  • 2 CrossRef citations
  • 0Altmetric
Distinguishing between entities – rationally based advances in the therapy of follicular lymphoma
Robert Marcus
Pages: 2285-2286
Published online: 01 Jul 2009
CitationforDistinguishing between entities – rationally based advances in the therapy of follicular lymphoma | Full Text | References | PDF (37.2 KB)
  • 10 Views
  • 0 CrossRef citations
  • 0Altmetric
David Galton, myelodysplasia and little me!
Ghulam Mufti
Pages: 2286-2287
Published online: 01 Jul 2009
CitationforDavid Galton, myelodysplasia and little me! | Full Text | References | PDF (38.4 KB)
  • 9 Views
  • 0 CrossRef citations
  • 0Altmetric
Chronic myeloid leukemia – Therapy in the 20th and 21st centuries
John Goldman
Pages: 2287-2288
Published online: 01 Jul 2009
CitationforChronic myeloid leukemia – Therapy in the 20th and 21st centuries | Full Text | References | PDF (38.6 KB)
  • 25 Views
  • 1 CrossRef citations
  • 0Altmetric
David Galton and the evolution of somatic cell populations
Lucio Luzzatto
Pages: 2288-2289
Published online: 01 Jul 2009
CitationforDavid Galton and the evolution of somatic cell populations | Full Text | PDF (37.3 KB)
  • 14 Views
  • 0 CrossRef citations
  • 0Altmetric
MRC trials in acute myeloblastic luekemia: Where have we got to?
Alan Burnett
Pages: 2289-2290
Published online: 01 Jul 2009
CitationforMRC trials in acute myeloblastic luekemia: Where have we got to? | Full Text | References | PDF (37.3 KB)
  • 64 Views
  • 4 CrossRef citations
  • 0Altmetric
David Galton – the thesis years
Martin Dyer
Pages: 2290-2291
Published online: 01 Jul 2009
CitationforDavid Galton – the thesis years | Full Text | PDF (36.5 KB)
  • 16 Views
  • 0 CrossRef citations
  • 0Altmetric
David Galton – a friend and teacher
Aaron Polliack
Page: 2291
Published online: 01 Jul 2009
CitationforDavid Galton – a friend and teacher | Full Text | PDF (42.1 KB)
  • 15 Views
  • 0 CrossRef citations
  • 0Altmetric
David A. G. Galton and the F.A.B. group
Georges Flandrin
Page: 2292
Published online: 01 Jul 2009
CitationforDavid A. G. Galton and the F.A.B. group | Full Text | PDF (29.5 KB)
  • 22 Views
  • 0 CrossRef citations
  • 0Altmetric
David A. G. Galton: a personal perspective
Lorne Brandes
Pages: 2292-2293
Published online: 01 Jul 2009
CitationforDavid A. G. Galton: a personal perspective | Full Text | PDF (35.4 KB)
  • 10 Views
  • 0 CrossRef citations
  • 0Altmetric
David Galton – Reminiscences
Richard Peto, Eve Wiltshaw & S.N. Batliwalla
Pages: 2293-2294
Published online: 01 Jul 2009
CitationforDavid Galton – Reminiscences | Full Text | PDF (51 KB)
  • 20 Views
  • 0 CrossRef citations
  • 0Altmetric
Reminiscences
Page: 2294
Published online: 01 Jul 2009
CitationforReminiscences | Full Text | PDF (20.5 KB)
  • 11 Views
  • 0 CrossRef citations
  • 0Altmetric

Commentary

Article Commentary
How to prevent deep vein thrombosis in myeloma patients receiving thalidomide or lenalidomide
Efstathios Kastritis & Meletios Dimopoulos
Pages: 2295-2297
Published online: 01 Jul 2009
First Page PreviewforHow to prevent deep vein thrombosis in myeloma patients receiving thalidomide or lenalidomide | Full Text | References | PDF (56.9 KB)
  • 115 Views
  • 4 CrossRef citations
  • 0Altmetric
Editorial
What is the correct philosophy for the treatment of multiple myeloma?
Morie A. Gertz
Pages: 2298-2299
Published online: 01 Jul 2009
CitationforWhat is the correct philosophy for the treatment of multiple myeloma? | Full Text | References | PDF (50.8 KB)
  • 340 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access
Article Commentary
Lessons of war: Progress in transplant conditioning regimens
Mark H. Kirschbaum
Pages: 2300-2301
Published online: 01 Jul 2009
CitationforLessons of war: Progress in transplant conditioning regimens | Full Text | References | PDF (52.3 KB)
  • 24 Views
  • 0 CrossRef citations
  • 0Altmetric
Article Commentary
FLT3 internal tandem duplication in low risk MDS: Clinical and basic science relevance
Deborah Rund
Pages: 2302-2303
Published online: 01 Jul 2009
CitationforFLT3 internal tandem duplication in low risk MDS: Clinical and basic science relevance | Full Text | References | PDF (53.5 KB)
  • 30 Views
  • 0 CrossRef citations
  • 0Altmetric
Editorial
Is autologous progenitor cell mobilization getting any easier?
Mark R. Litzow
Pages: 2304-2305
Published online: 01 Jul 2009
CitationforIs autologous progenitor cell mobilization getting any easier? | Full Text | References | PDF (54.5 KB)
  • 235 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access
Article Commentary
Chronic lymphocytic lymphoma: Another example of parental favoritism?
Vijayakrishna K. Gadi
Pages: 2306-2307
Published online: 01 Jul 2009
CitationforChronic lymphocytic lymphoma: Another example of parental favoritism? | Full Text | References | PDF (53.1 KB)
  • 24 Views
  • 2 CrossRef citations
  • 0Altmetric
Article Commentary
Viral infection or reactivation in patients during treatment with dasatinib: A call for screening?
Harrys A. Torres & Roy F. Chemaly
Pages: 2308-2309
Published online: 01 Jul 2009
CitationforViral infection or reactivation in patients during treatment with dasatinib: A call for screening? | Full Text | References | PDF (51.5 KB)
  • 182 Views
  • 8 CrossRef citations
  • 0Altmetric

Review

Review Article
Strategies for overcoming imatinib resistance in chronic myeloid leukemia
Lisa Kujawski & Moshe Talpaz
Pages: 2310-2322
Published online: 01 Jul 2009
AbstractforStrategies for overcoming imatinib resistance in chronic myeloid leukemia | Full Text | References | PDF (295.2 KB)
  • 252 Views
  • 27 CrossRef citations
  • 0Altmetric
Review Article
Myeloma cells and bone marrow osteoblast interactions: Role in the development of osteolytic lesions in multiple myeloma
Nicola Giuliani & Vittorio Rizzoli
Pages: 2323-2329
Published online: 01 Jul 2009
AbstractforMyeloma cells and bone marrow osteoblast interactions: Role in the development of osteolytic lesions in multiple myeloma | Full Text | References | PDF (374.7 KB)
  • 345 Views
  • 40 CrossRef citations
  • 0Altmetric

Original Article: Clinical

Article
Prophylactic low-dose aspirin is effective antithrombotic therapy for combination treatments of thalidomide or lenalidomide in myeloma
Ruben Niesvizky, Déborah Martínez-Baños, Jessica Jalbrzikowski, Paul Christos, Jessica Furst, Maria De Sancho, Tomer Mark, Roger Pearse, Madhu Mazumdar, Faiza Zafar, Karen Pekle, John Leonard, David Jayabalan & Morton Coleman
Pages: 2330-2337
Published online: 01 Jul 2009
AbstractforProphylactic low-dose aspirin is effective antithrombotic therapy for combination treatments of thalidomide or lenalidomide in myeloma | Full Text | References | PDF (122.2 KB)
  • 725 Views
  • 53 CrossRef citations
  • 0Altmetric
Article
Combination of rituximab and oral melphalan and prednisone in newly diagnosed multiple myeloma
Rachid Baz, Suzanne Fanning, Lori Kunkel, Sameh Gaballa, Mary Ann Karam, Janice Reed, Megan Kelly & Mohamad Hussein
Pages: 2338-2344
Published online: 01 Jul 2009
AbstractforCombination of rituximab and oral melphalan and prednisone in newly diagnosed multiple myeloma | Full Text | References | PDF (226.8 KB)
  • 206 Views
  • 14 CrossRef citations
  • 0Altmetric
Article
Escalation therapy with bortezomib, dexamethasone and bendamustine for patients with relapsed or refractory multiple myeloma
Roland Fenk, Mark Michael, Fabian Zohren, Thorsten Graef, Akos Czibere, Ingmar Bruns, Frank Neumann, Barbara Fenk, Rainer Haas & Guido Kobbe
Pages: 2345-2351
Published online: 01 Jul 2009
AbstractforEscalation therapy with bortezomib, dexamethasone and bendamustine for patients with relapsed or refractory multiple myeloma | Full Text | References | PDF (169.3 KB)
  • 411 Views
  • 37 CrossRef citations
  • 0Altmetric
Article
Fludarabine and treosulfan: A novel modified myeloablative regimen for allogeneic hematopoietic stem-cell transplantation with effective antileukemia activity in patients with acute myeloid leukemia and myelodysplastic syndromes
Avichai Shimoni, Izhar Hardan, Noga Shem-Tov, Avital Rand, Ronit Yerushalmi & Arnon Nagler
Pages: 2352-2359
Published online: 01 Jul 2009
AbstractforFludarabine and treosulfan: A novel modified myeloablative regimen for allogeneic hematopoietic stem-cell transplantation with effective antileukemia activity in patients with acute myeloid leukemia and myelodysplastic syndromes | Full Text | References | PDF (277.5 KB)
  • 269 Views
  • 44 CrossRef citations
  • 0Altmetric
Article
Paclitaxel and filgrastim for hematopoietic progenitor cell mobilization in patients with hematologic malignancies after failure of a prior mobilization regimen
Trevor McKibbin, Julianna Burzynski, Rebecca Greene, Jose Ochoa-Bayona, T. W. Tsai, Natalie Callander & Cesar Freytes
Pages: 2360-2366
Published online: 01 Jul 2009
AbstractforPaclitaxel and filgrastim for hematopoietic progenitor cell mobilization in patients with hematologic malignancies after failure of a prior mobilization regimen | Full Text | References | PDF (89.8 KB)
  • 67 Views
  • 3 CrossRef citations
  • 0Altmetric
Article
Characteristics of and risk factors for pneumonia in patients with hematological malignancies developing fever after autologous blood stem cell transplantation
Noemí Puig, Javier De La Rubia, Isidro Jarque, Miguel Salavert, Federico Moscardó, Jaime Sanz, Ignacio Lorenzo, Pau Montesinos, Guillermo Martín, Jesús Martínez, Guillermo Sanz, Margarita Blanes & Miguel Sanz
Pages: 2367-2374
Published online: 01 Jul 2009
AbstractforCharacteristics of and risk factors for pneumonia in patients with hematological malignancies developing fever after autologous blood stem cell transplantation | Full Text | References | PDF (147.6 KB)
  • 107 Views
  • 11 CrossRef citations
  • 0Altmetric
Article
Thrombocytosis in myelodysplastic and myelodysplastic/myeloproliferative syndromes
Dhatri Kodali, Hector Mesa, Ajay Rawal, Qing Cao & Pankaj Gupta
Pages: 2375-2380
Published online: 01 Jul 2009
AbstractforThrombocytosis in myelodysplastic and myelodysplastic/myeloproliferative syndromes | Full Text | References | PDF (201.6 KB)
  • 193 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
Estimated number of cases, regional distribution and survival of patients diagnosed with acute myeloid leukemia between 1996 and 2000 in Rio Grande do Sul, Brazil
Marcelo Capra, Líbia Vilella, Waldir Veiga Pereira, Virgínia Maria Coser, Mário Sérgio Fernandes, Marco Antônio Schilling, Denise Almeida, Mauro Gross, Márcia Leite, Tânia Hellwig, Gilca Natchigal, Alice Zelmanowicz, Giorgio Paskulin, Jorge Neumann & Lúcia Silla
Pages: 2381-2386
Published online: 01 Jul 2009
AbstractforEstimated number of cases, regional distribution and survival of patients diagnosed with acute myeloid leukemia between 1996 and 2000 in Rio Grande do Sul, Brazil | Full Text | References | PDF (291.9 KB)
  • 102 Views
  • 14 CrossRef citations
  • 0Altmetric
Article
Birth order pattern in the inheritance of chronic lymphocytic leukaemia and related lymphoproliferative disease
Viggo Jønsson, Geir Tjønnfjord, Sven Ove Samuelsen, Tom Johannesen, Jørgen Olsen, Gabrielle Sellick, Richard Houlston, Martin Yuille & Daniel Catovsky
Pages: 2387-2396
Published online: 01 Jul 2009
AbstractforBirth order pattern in the inheritance of chronic lymphocytic leukaemia and related lymphoproliferative disease | Full Text | References | PDF (286.6 KB)
  • 65 Views
  • 8 CrossRef citations
  • 0Altmetric
Article
Phase II study of denileukin diftitox for previously treated indolent non-Hodgkin lymphoma: Final results of E1497
Timothy M. Kuzel, Shuli Li, John Eklund, Francine Foss, Randy Gascoyne, Neil Abramson, John F. Schwerkoske, Edie Weller & Sandra J. Horning
Pages: 2397-2402
Published online: 01 Jul 2009
AbstractforPhase II study of denileukin diftitox for previously treated indolent non-Hodgkin lymphoma: Final results of E1497 | Full Text | References | PDF (88.6 KB)
  • 112 Views
  • 18 CrossRef citations
  • 0Altmetric
Article
Biologic predictors in follicular lymphoma: Importance of markers of immune response
Todd Kelley, Rose Beck, Ahmed Absi, Tao Jin, Brad Pohlman & Eric Hsi
Pages: 2403-2411
Published online: 01 Jul 2009
AbstractforBiologic predictors in follicular lymphoma: Importance of markers of immune response | Full Text | References | PDF (1.2 MB)
  • 155 Views
  • 37 CrossRef citations
  • 0Altmetric
Article
Methylprednisolone-rituximab is an effective salvage therapy for patients with relapsed chronic lymphocytic leukemia including those with unfavorable cytogenetic features
Deborah A. Bowen, Timothy G. Call, Greg D. Jenkins, Clive S. Zent, Susan M. Schwager, Daniel L. Van Dyke, Diane F. Jelinek, Neil E. Kay & Tait D. Shanafelt
Pages: 2412-2417
Published online: 01 Jul 2009
AbstractforMethylprednisolone-rituximab is an effective salvage therapy for patients with relapsed chronic lymphocytic leukemia including those with unfavorable cytogenetic features | Full Text | References | PDF (158.7 KB)
  • 768 Views
  • 74 CrossRef citations
  • 0Altmetric

Original Article: Research

Article
Specific pattern of protein expression in acute myeloid leukemia harboring FLT3-ITD mutations
Sebastian Scholl, Christian Melle, Annett Bleul, Baerbel Spies-Weisshart, Christa Kunert, Klaus Höffken & Ferdinand von Eggeling
Pages: 2418-2423
Published online: 01 Jul 2009
AbstractforSpecific pattern of protein expression in acute myeloid leukemia harboring FLT3-ITD mutations | Full Text | References | PDF (161.1 KB)
  • 170 Views
  • 2 CrossRef citations
  • 0Altmetric
Article
CD52 over-expression affects rituximab-associated complement-mediated cytotoxicity but not antibody-dependent cellular cytotoxicity: Preclinical evidence that targeting CD52 with alemtuzumab may reverse acquired resistance to rituximab in non-Hodgkin lymphoma
Raymond I. Cruz, Francisco J. Hernandez-Ilizaliturri, Scott Olejniczak, George Deeb, Joy Knight, Paul Wallace, Beth L. Thurberg, William Kennedy & Myron S. Czuczman
Pages: 2424-2436
Published online: 01 Jul 2009
AbstractforCD52 over-expression affects rituximab-associated complement-mediated cytotoxicity but not antibody-dependent cellular cytotoxicity: Preclinical evidence that targeting CD52 with alemtuzumab may reverse acquired resistance to rituximab in non-Hodgkin lymphoma | Full Text | References | PDF (1.6 MB)
  • 311 Views
  • 28 CrossRef citations
  • 0Altmetric

Letter to the Editor

Letter
Analysis of FLT3 gene mutations in de novo myelodysplastic syndromes. FLT3 internal tandem duplication detected in a case of refractory anemia
Vassiliki Pappa, Sotirios Papageorgiou, Frieda Kontsioti, Efstathios Papageorgiou, Panayioula Tsiotra, John Dervenoulas & Theofanis Economopoulos
Pages: 2437-2440
Published online: 01 Jul 2009
First Page PreviewforAnalysis of FLT3 gene mutations in de novo myelodysplastic syndromes. FLT3 internal tandem duplication detected in a case of refractory anemia | Full Text | References | PDF (132.4 KB)
  • 47 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter
Complete molecular remission induced by concomitant Cladribine – Rituximab treatment in a case of multi-resistant Hairy Cell Leukemia
Francesco Forconi, Francesca Toraldo, Elisa Sozzi, Teresa Amato, Donatella Raspadori & Francesco Lauria
Pages: 2441-2443
Published online: 01 Jul 2009
First Page PreviewforComplete molecular remission induced by concomitant Cladribine – Rituximab treatment in a case of multi-resistant Hairy Cell Leukemia | Full Text | References | PDF (62.9 KB)
  • 79 Views
  • 17 CrossRef citations
  • 0Altmetric
Letter
High relapse rate after a brief chemotherapy course and involved-field radiotherapy in early-stage Hodgkin lymphoma
Massimo Magagnoli, Monica Balzarotti, Licia Vanessa Siracusano, Michele Spina, Luciano Isa, Emanuela Morenghi, Umberto Tirelli & Armando Santoro
Pages: 2444-2446
Published online: 01 Jul 2009
First Page PreviewforHigh relapse rate after a brief chemotherapy course and involved-field radiotherapy in early-stage Hodgkin lymphoma | Full Text | References | PDF (123.3 KB)
  • 35 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter
Recurrent hemophagocytic lymphohistiocytosis accompanied by Kikuchi's disease
Ying-Wei Lin, Hisanori Horiuchi, Ikuyo Ueda & Mitsuhiko Nambu
Pages: 2447-2451
Published online: 01 Jul 2009
First Page PreviewforRecurrent hemophagocytic lymphohistiocytosis accompanied by Kikuchi's disease | Full Text | References | PDF (289.4 KB)
  • 142 Views
  • 22 CrossRef citations
  • 0Altmetric
Letter
Phrenic nerve paralysis due to vincristine
Paul Gilliland & Mark Holguin
Pages: 2452-2453
Published online: 01 Jul 2009
CitationforPhrenic nerve paralysis due to vincristine | Full Text | References | PDF (57 KB)
  • 69 Views
  • 8 CrossRef citations
  • 0Altmetric
Letter
Pregnancy in patients with chronic myeloid leukemia treated with imatinib
Mehmet Yilmaz, Osman Demirhan, Ercan Kuçukosmanoglu, Mustafa Pehlivan, Vahap Okan, Ozcan Balat & Sacide Pehlivan
Pages: 2454-2456
Published online: 01 Jul 2009
First Page PreviewforPregnancy in patients with chronic myeloid leukemia treated with imatinib | Full Text | References | PDF (60.9 KB)
  • 141 Views
  • 10 CrossRef citations
  • 0Altmetric
Letter
Characterization of high-hyperdiploidy in childhood acute lymphoblastic leukemia with gain of a single chromosome 21
Angela Brown, Felix Niggli, Heinz Hengartner, Ueli Caflisch, Luisa Nobile, Thomas Kuhne, Regula Angst, Jean-Pierre Bourquin & David Betts
Pages: 2457-2460
Published online: 01 Jul 2009
First Page PreviewforCharacterization of high-hyperdiploidy in childhood acute lymphoblastic leukemia with gain of a single chromosome 21 | Full Text | References | PDF (163.8 KB)
  • 96 Views
  • 2 CrossRef citations
  • 0Altmetric
Letter
Parvovirus B19 acute infection and a reactivation of cytomegalovirus and herpesvirus 6 in a chronic myeloid leukemia patient during treatment with dasatinib (BMS-354825)
Ricardo García-Muñoz, Alicia Galar, Cristina Moreno, Paula Rodríguez-Otero, Elena Panizo-Morgado, Mariano Ponz-Sarvisê, Mirian Fernandez-Alonso, Manuel Rubio, Juana Merino, Braulia Cuesta, Carlos Panizol & Felipe Prosper
Pages: 2461-2464
Published online: 01 Jul 2009
First Page PreviewforParvovirus B19 acute infection and a reactivation of cytomegalovirus and herpesvirus 6 in a chronic myeloid leukemia patient during treatment with dasatinib (BMS-354825) | Full Text | References | PDF (431 KB)
  • 186 Views
  • 19 CrossRef citations
  • 0Altmetric
Letter
Lenalidomide-associated hypothyroidism
Smitha Menon, Thomas Habermann & Thomas Witzig
Pages: 2465-2467
Published online: 01 Jul 2009
First Page PreviewforLenalidomide-associated hypothyroidism | Full Text | References | PDF (97.6 KB)
  • 231 Views
  • 15 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Direct and indirect costs for patients with myeloproliferative neoplasms
Jingbo Yu et al.
Article | Published online: 27 Apr 2024
Open Access
Targets and treatments in primary CNS lymphoma
Christina von Roemeling et al.
Review Article | Published online: 24 Apr 2024
Open Access
Challenges in management of older patients with chronic myeloid leukemia
Jessica M. Stempel et al.
Review Article | Published online: 23 Apr 2024
Effect of tyrosine kinase inhibitors on male fertility in patients with chronic phase chronic myeloid leukemia
George Nesr et al.
Article | Published online: 23 Apr 2024
Open Access
View all latest articles